{"schema_version":"secwatch.filing_event.v1","accession":"0001964738-24-000017","form_type":"8-K","ticker":"SOLV","cik":"0001964738","company_name":"Solventum Corp","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.286568+00:00","generated_at":"2026-05-31T11:21:01.292756+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Solventum Q2 GAAP EPS $0.51, adj EPS $1.56; raises full-year guidance","bullets":["Reported sales $2.081B (+0.2% YoY); organic sales +1.3%; MedSurg and HIS drove growth.","GAAP operating margin 11.7%; adjusted operating margin 20.7%; adjusted EPS $1.56.","Generated $355M cash from ops; free cash flow $297M.","Raises full-year 2024 organic sales growth and adjusted EPS guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001964738-24-000017","json":"https://secwatch.observer/filing/0001964738-24-000017.json","markdown":"https://secwatch.observer/filing/0001964738-24-000017.md","text":"https://secwatch.observer/filing/0001964738-24-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1964738/000196473824000017/0001964738-24-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1964738/000196473824000017/solv-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:21:01.292756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}